Risk of incident heart failure after COVID-19 recovery: a systematic review and meta-analysis
M Zuin, G Rigatelli, L Roncon, G Pasquetto… - Heart failure reviews, 2023 - Springer
Patients recovered from COVID-19 have an increased incidence of cardiovascular disease
and heart structural changes. The aim of the present manuscript is to assess the risk of …
and heart structural changes. The aim of the present manuscript is to assess the risk of …
Machine-learning-based adverse drug event prediction from observational health data: A review
Adverse drug events (ADEs) are responsible for a significant number of hospital admissions
and fatalities. Machine learning models have been developed to assess individual patient …
and fatalities. Machine learning models have been developed to assess individual patient …
Trends in cardiovascular mortality related to atrial fibrillation in the United States, 2011 to 2018
Y Tanaka, NS Shah, R Passman… - Journal of the …, 2021 - Am Heart Assoc
Background Prevalence of atrial fibrillation (AF) continues to increase and is associated with
significant cardiovascular morbidity and mortality. To inform prevention strategies aimed at …
significant cardiovascular morbidity and mortality. To inform prevention strategies aimed at …
Population-based penetrance of deleterious clinical variants
Importance Population-based assessment of disease risk associated with gene variants
informs clinical decisions and risk stratification approaches. Objective To evaluate the …
informs clinical decisions and risk stratification approaches. Objective To evaluate the …
Accuracy of Japanese claims data in identifying diabetes‐related complications
K Fujihara, M Yamada‐Harada… - … and Drug Safety, 2021 - Wiley Online Library
Purpose To evaluate the accuracy of various claims‐based definitions of diabetes‐related
complications (coronary artery disease [CAD], heart failure, cerebrovascular disease and …
complications (coronary artery disease [CAD], heart failure, cerebrovascular disease and …
Higher mortality among lean patients with non‐alcoholic fatty liver disease despite fewer metabolic comorbidities
Summary Background & Aims Non‐alcoholic fatty liver disease (NAFLD) can develop in
individuals who are not overweight. Whether lean persons with NAFLD have lower mortality …
individuals who are not overweight. Whether lean persons with NAFLD have lower mortality …
Lipoprotein (a) and major adverse cardiovascular events in patients with or without baseline atherosclerotic cardiovascular disease
Abstract Background Lipoprotein (a)[Lp (a)] is associated with an increased risk of
atherosclerotic cardiovascular disease (ASCVD). However, whether the optimal Lp (a) …
atherosclerotic cardiovascular disease (ASCVD). However, whether the optimal Lp (a) …
[HTML][HTML] Trends of sex differences in clinical outcomes after myocardial infarction in the United States
Background Female patients have been shown to experience worse clinical outcomes after
acute myocardial infarction (AMI) compared with male patients. However, it is unclear what …
acute myocardial infarction (AMI) compared with male patients. However, it is unclear what …
[HTML][HTML] Risk for stroke and myocardial infarction with abiraterone versus enzalutamide in metastatic prostate cancer patients
AA Kulkarni, N Rubin, A Tholkes, S Shah, CJ Ryan… - Esmo Open, 2021 - Elsevier
Background Abiraterone and enzalutamide use is associated with significant cardiovascular
(CV) morbidity in clinical trials, but the magnitude and clinical relevance of this association in …
(CV) morbidity in clinical trials, but the magnitude and clinical relevance of this association in …
Opportunistic assessment of ischemic heart disease risk using abdominopelvic computed tomography and medical record data: a multimodal explainable artificial …
Current risk scores using clinical risk factors for predicting ischemic heart disease (IHD)
events—the leading cause of global mortality—have known limitations and may be …
events—the leading cause of global mortality—have known limitations and may be …